Published by Harborside • 3 years ago
To our clients and colleagues,
Like all companies, Harborside has been closely monitoring developments relating to the novel coronavirus, COVID-19. We take seriously our responsibilities as a publisher of vital information about the treatment of patients with cancer. Harborside has long had a Business Continuity Plan in place to ensure that our products will not be affected by external disruptions. We are working closely with our vendors to make certain that the delivery of our content remains on time and of the highest quality.
We also take our commitment to our employees seriously. To that end, we have made the decision for all of our employees to work remotely as a precaution against the spread of the novel coronavirus. This includes all staff at our Huntington, NY, and Lawrenceville, NJ, offices. Nonessential business travel for our employees has also been suspended. Our company infrastructure will ensure uninterrupted service for our print and digital products, and we will continue serving our clients at the same high level to which they have become accustomed.
We sympathize deeply with people across the world whose health has been impacted by the virus, and we thank the many healthcare workers, researchers, scientists, and others who are working tirelessly to mitigate the impact of COVID-19.
If you have questions about our response to the novel coronavirus or would like more information, please contact Anthony Cutrone (email@example.com) or Conor Lynch (firstname.lastname@example.org).